Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Current Chateaus: Advancement and Style - 2RFK Jr.'s vaccine panel delays hepatitis B shot vote after chaotic meeting
- 3This Week In Space podcast: Episode 189 — Privatizing Orbit
- 4Sound Maturing: Wellbeing Tips for Each Life Stage
- 5Game theory explains why reasonable parents make vaccine choices that fuel outbreaks
- One third of Spanish pork export certificates blocked since swine fever outbreak, minister says
- Limited Rain Chances in Brazil Boost Coffee Prices
- The most effective method to Involve Handshakes for Compromise and Compromise
- As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves
- Find Your Ideal Tea: Six Particular Assortments
- What are parents to do as doctors clash with Trump administration over vaccines?
- Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
- Is 'Stranger Things' releasing one last episode? The 'Conformity Gate' fan theory explained as speculation mounts.
- Benedict Cumberbatch takes on something even Sherlock can’t solve: male grief
